Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Discovery of genes could lead to development of novel therapies for EBV-related cancers

Discovery of genes could lead to development of novel therapies for EBV-related cancers

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

Blood test using infrared spectroscopy can help detect two cancer types

Blood test using infrared spectroscopy can help detect two cancer types

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

TUM scientists discover emergency shut-off switch for T cell Non-Hodgkin's lymphoma

TUM scientists discover emergency shut-off switch for T cell Non-Hodgkin's lymphoma

New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Novel gene expression signature assay could help enhance lymphoma management

Novel gene expression signature assay could help enhance lymphoma management

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Study identifies late effects that may interfere with work status of young adult cancer survivors

Study identifies late effects that may interfere with work status of young adult cancer survivors

Plant virus-based system can be used to deliver anti-cancer drugs

Plant virus-based system can be used to deliver anti-cancer drugs

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes